{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:28:11Z","timestamp":1795102091886,"version":"4.10.3"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2024.136538","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000}}],"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260134"],"award-info":[{"award-number":["82260134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijbiomac.2024.136538","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T13:20:50Z","timestamp":1728652850000},"page":"136538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P3","title":["RETRACTED: LINC00894 targets Annexin A2 to regulate oxaliplatin resistance in hepatocellular carcinoma: ANXA2 protein function"],"prefix":"10.1016","volume":"281","author":[{"given":"Junling","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengmeng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongshuai","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingzhuang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136538_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.suc.2020.02.013","article-title":"Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma","volume":"100","author":"Mejia","year":"2020","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.ijbiomac.2024.136538_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/JHC.S159805","article-title":"Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions","volume":"6","author":"Stavraka","year":"2019","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136538_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136538_bb0020","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1007\/s00261-024-04490-7","article-title":"A real-world study of tyrosine kinase inhibitors plus anti-PD-1 immunotherapy with or without chemoembolization for hepatocellular carcinoma patients with main portal vein invasion","volume":"49","author":"Song","year":"2024","journal-title":"Abdominal Radiology"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.136538_bb0025","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3349\/ymj.2018.59.10.1143","article-title":"Cancer metabolism as a mechanism of treatment resistance and potential therapeutic target in hepatocellular carcinoma","volume":"59","author":"Lee","year":"2018","journal-title":"Yonsei Med. J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136538_bb0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.21.01963","article-title":"Arterial chemotherapy of Oxaliplatin plus fluorouracil versus Sorafenib in advanced hepatocellular carcinoma: a biomolecular exploratory, randomized, phase III trial (FOHAIC-1)","volume":"40","author":"Lyu","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.136538_bb0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamaoncol.2019.0250","article-title":"Sorafenib plus hepatic arterial infusion of Oxaliplatin, fluorouracil, and Leucovorin vs Sorafenib alone for hepatocellular carcinoma with portal vein invasion: a randomized clinical trial","volume":"5","author":"He","year":"2019","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136538_bb0040","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41467-023-38753-6","article-title":"Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase","volume":"14","author":"Zhan","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136538_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2018.02.008","article-title":"Hepatic arterial infusion of oxaliplatin plus fluorouracil\/leucovorin vs. sorafenib for advanced hepatocellular carcinoma","volume":"69","author":"Lyu","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136538_bb0050","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1002\/hep.32079","article-title":"LSD1-Demethylated LINC01134 confers Oxaliplatin resistance through SP1-induced p62 transcription in HCC","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136538_bb0055","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","article-title":"Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a ceRNA","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.136538_bb0060","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/EBC20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays Biochem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.136538_bb0065","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","article-title":"Mechanisms of long noncoding RNA function in development and disease","volume":"73","author":"Schmitz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2024.136538_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106418","article-title":"Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy","volume":"184","author":"Hashemi","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.136538_bb0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/CMR.0000000000000560","article-title":"Long noncoding RNA X-inactive specific transcript promotes malignant melanoma progression and oxaliplatin resistance","volume":"29","author":"Pan","year":"2019","journal-title":"Melanoma Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.136538_bb0080","first-page":"3049","article-title":"The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326\/IRS1 axis in gastric cancer","volume":"24","author":"Song","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.136538_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2021.12.026","article-title":"SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback","volume":"528","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.136538_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.14218\/JCTH.2020.00001","article-title":"Management and treatment of hepatocellular carcinoma with immunotherapy: a review of current and future options","volume":"8","author":"Ghavimi","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136538_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136538_bb0100","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/ijms19051310","article-title":"Noncoding RNA:RNA regulatory networks in Cancer","volume":"19","author":"Chan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136538_bb0105","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s42255-022-00616-7","article-title":"Long non-coding RNA SNHG6 couples cholesterol sensing with mTORC1 activation in hepatocellular carcinoma","volume":"4","author":"Liu","year":"2022","journal-title":"Nat. Metab."},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2024.136538_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.semcancer.2022.05.013","article-title":"Long non-coding RNA and RNA-binding protein interactions in cancer: experimental and machine learning approaches","volume":"86","author":"Shaath","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136538_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12672-022-00520-2","article-title":"Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression","volume":"13","author":"Chen","year":"2022","journal-title":"Discov. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136538_bb0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1134\/S0006297918050139","article-title":"Downregulation of LINC00894-002 contributes to tamoxifen resistance by enhancing the TGF-beta signaling pathway","volume":"83","author":"Zhang","year":"2018","journal-title":"Biochemistry (Mosc.)"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.136538_bb0125","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/ijc.31817","article-title":"Annexin A2 (ANX A2): an emerging biomarker and potential therapeutic target for aggressive cancers","volume":"144","author":"Sharma","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.136538_bb0130","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1038\/s41388-021-01786-6","article-title":"EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis","volume":"40","author":"Mao","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.136538_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/bmm-2020-0629","article-title":"ANXA2 is a potential marker for the diagnosis of human cervical cancer","volume":"15","author":"Wang","year":"2021","journal-title":"Biomark. Med."},{"key":"10.1016\/j.ijbiomac.2024.136538_bb0140","doi-asserted-by":"crossref","first-page":"4035460","DOI":"10.1155\/2019\/4035460","article-title":"ANXA2 silencing inhibits proliferation, invasion, and migration in gastric Cancer cells","volume":"2019","author":"Xie","year":"2019","journal-title":"J. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.136538_bb0145","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41419-022-05172-2","article-title":"LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.136538_bb0150","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00262-021-03055-7","article-title":"LncRNA MIR155HG induces M2 macrophage polarization and drug resistance of colorectal cancer cells by regulating ANXA2","volume":"71","author":"Zhou","year":"2022","journal-title":"Cancer Immunol. Immunother."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2024.136538","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000}},{"DOI":"10.1016\/j.ijbiomac.2026.153938","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000}},{"DOI":"10.1016\/j.ijbiomac.2026.153938","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"record-id":"72370"},{"DOI":"10.1016\/j.ijbiomac.2026.153938","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024073471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024073471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:57:28Z","timestamp":1782860248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024073471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"alternative-id":["S0141813024073471"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136538","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: LINC00894 targets Annexin A2 to regulate oxaliplatin resistance in hepatocellular carcinoma: ANXA2 protein function","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"136538"}}